Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
M-001
BIOLOGICAL
2 trials
Sponsors
BiondVax Pharmaceuticals ltd.
Conditions
Influenza
Phase 2
Phase II Study to Assess Safety & Immunogenicity of Multimeric-001 Influenza Vaccine, Followed by TIV
Completed
NCT02293317
BiondVax Pharmaceuticals ltd.
Influenza
Start: 2014-11-30
End: 2015-06-30
Updated: 2016-02-23
Phase 3
A Pivotal Trial to Assess the Safety and Clinical Efficacy of the M-001 as a Standalone Universal Flu Vaccine
Completed
NCT03450915
BiondVax Pharmaceuticals ltd.
Influenza
Start: 2018-08-01
End: 2020-10-23
Updated: 2021-10-05
Related Papers
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine
Frontiers in Immunology
2022-04-07
24 citations